April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
The Effects of Intravitreal Anti-VEGF Injections on Ocular Perfusion Pressure
Author Affiliations & Notes
  • E. Reichel
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts
  • H. R. Shah
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts
  • L. Smithen
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  E. Reichel, None; H.R. Shah, None; L. Smithen, None.
  • Footnotes
    Support  Falck Medical, Inc. provided the FAT1 device.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5032. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Reichel, H. R. Shah, L. Smithen; The Effects of Intravitreal Anti-VEGF Injections on Ocular Perfusion Pressure. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5032.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Blood flow into the eye is determined by the ocular perfusion pressure (OPP). OPP is the difference between the mean central retinal artery pressure (MCRAP) and the intraocular pressure (IOP) (OPP = MCRAP - IOP).1 Intravitreal anti-VEGF injections can increase intraocular pressure, thereby reducing retinal blood flow.2 The aim of this study was to investigate the effect of intravitreal injections on OPP.

Methods: : The OPP, MCRAP, IOP and Ocular Pulse Amplitude (OPA) were measured using the Falck Medical Multifunction Applanation Tonometer (FAT1) in 20 eyes of 20 patients immediately before and after an intravitreal anti-VEGF injection. Twelve eyes received Avastin (0.5mg), and 8 eyes Lucentis (0.5mg). Mean upright ipsilateral brachial blood pressure (MBBP) was recorded.

Results: : The mean age and MBBP was 79.7+/- 8 years and 93.4 +/-11 mmHg. MCRAP was 50% of MBBP. The mean post-injection increase in IOP was 11.4 mmHg, p = <0.0001 (29.9-18.5). The mean post-injection decrease in MCRAP was 10.8 mmHg, p = 0.006 (47.2-36.4). The mean post-injection decrease in OPP was 12.5 mmHg, p = 0.003 (28.6-16.1). Ocular perfusion pressure was reduced in 18 eyes following intravitreal injection. In 7 eyes, OPP declined to < 15 mmHg from increased IOP and decreased MCRAP. In 2 eyes the OPP decreased to zero from increased IOP and decreased MCRAP.

Conclusions: : Based on the results of this study, intravitreal anti-VEGF injections can reduce MCRAP and OPP. This technology may help identify those patients at risk for having a decline in OPP, and therefore may enhance the safety of administration of anti-VEGF injections.1 Kaufman PL, Alm A. Adlers Physiology of the Eye. Tenth Edition 2003;764-67.2 Papadopoulou DN, Medrinos E, Mangioris G, et al. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. Ophthalmology.2009;116:1755-61.

Keywords: blood supply • drug toxicity/drug effects • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×